D
Enliven Therapeutics, Inc. ELVN
$20.70 $0.381.87% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -20.99% -19.14% -24.36% -37.97% -60.68%
Total Depreciation and Amortization 0.64% 0.97% 6.73% 11.31% 18.11%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 151.51% 123.19% 132.75% 87.30% 44.00%
Change in Net Operating Assets 669.48% -146.06% -424.13% 141.45% 92.54%
Cash from Operations 2.21% -15.95% -19.46% -20.27% -51.99%
Capital Expenditure -248.08% 68.12% 70.47% 75.42% 77.78%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -244.14% 89.98% 75.75% 101.08% 68.06%
Cash from Investing -244.14% 89.96% 75.75% 101.05% 68.08%
Total Debt Issued -- -- -- -- -200.00%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 2.42% -82.88% -45.33% -61.69% 208.79%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 100.00% 95.91%
Cash from Financing 183.08% -50.49% -43.16% -59.76% -60.53%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 178.05% 66.76% -2.56% 317.46% -186.73%